1. Home
  2. AVDL vs BKV Comparison

AVDL vs BKV Comparison

Compare AVDL & BKV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.69

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo BKV Corporation

BKV

BKV Corporation

HOLD

Current Price

$30.31

Market Cap

2.5B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVDL
BKV
Founded
2015
2015
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.5B
IPO Year
1996
2024

Fundamental Metrics

Financial Performance
Metric
AVDL
BKV
Price
$21.69
$30.31
Analyst Decision
Buy
Strong Buy
Analyst Count
8
7
Target Price
$19.14
$31.14
AVG Volume (30 Days)
1.6M
682.7K
Earning Date
03-02-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.53
Revenue
$248,517,000.00
$822,525,000.00
Revenue This Year
$65.47
$54.72
Revenue Next Year
$30.88
$45.42
P/E Ratio
N/A
$54.86
Revenue Growth
79.88
33.41
52 Week Low
$6.38
$15.00
52 Week High
$23.57
$30.83

Technical Indicators

Market Signals
Indicator
AVDL
BKV
Relative Strength Index (RSI) 63.88 59.88
Support Level $21.52 $28.41
Resistance Level $21.69 $30.04
Average True Range (ATR) 0.06 1.17
MACD -0.01 0.11
Stochastic Oscillator 66.67 72.17

Price Performance

Historical Comparison
AVDL
BKV

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About BKV BKV Corporation

BKV Corp is a growth-driven energy company. Its core business is production of natural gas from its owned and operated upstream businesses. It operates in four business lines: natural gas production, natural gas gathering, processing and transportation (natural gas midstream business), power generation and carbon capture, utilization, and sequestration (CCUS).

Share on Social Networks: